Snow Software Introduces New Global Partner Program to Drive Exponential Growth in Channel Ecosystem
1.2.2023 17:00:00 EET | Business Wire | Press release
Snow Software, the global leader in technology intelligence, today announced a new global partner program designed to enable partners to support customers as they face complex market challenges around managing cost and mitigating risk, while delivering value more efficiently and effectively with Snow. The new program aims to drive exponential growth in the Snow channel ecosystem, creating new opportunities for partners to tap into an estimated and growing $11.5 billion Technology Intelligence market.
Developed in collaboration with its current channel ecosystem, the new Snow partner program includes better support for multiple business models of partners, encouraging the creation of value-added services and driving tangible customer success by leveraging Snow technology. The program includes more partner incentives and rewards than the current program, while streamlining collaboration with Snow to better deliver value to shared customers.
“Today’s economic climate demands more from every organization’s IT technology environment, which means that our partners have a greater responsibility to provide visibility, governance and optimization services for their customers,” said Vinod Chumber, Vice President of Ecosystem Sales at Snow. “In order to ensure our partners can deliver excellent outcomes, it was essential to create a new program that better enabled them with the right resources, education and solutions to succeed. As a partner-centric organization, we believe that our new program combined with our Snow Atlas platform is a powerful combination to address the turbulent market customers and partners face today. The new program is just the beginning as we continue to invest in our partners and create a rich ecosystem enabled to take advantage of the vision for Technology Intelligence.”
Creating transparency with the market, the partner portal will feature real-time dashboards featuring each partner’s strong record of success and specializations to arm customers with insight on the best partners suited to their needs. The new framework will remove channel conflicts, empowering partners to build new, value-add services and work closely with the Snow wider teams to drive customer success. Additional new program benefits include:
- Sales rewards and points system to recognize the investment that individuals within the partner organization are making;
- Self-service capabilities to create new operational efficiencies within the partner portal;
- Business development funds to market and promote partner sales offerings built on top of Snow technology;
- Shadowing programs to drive customer success and adoption of Snow best practices and certification opportunities;
- Free access to Snow e-learning to empower partners with the latest knowledge on the Snow product and solution portfolio;
- Snow Champion Program to recognize and reward individuals for their contribution to the Snow community; and
- Ongoing recognition and rewards opportunities including annual partner awards to celebrate the success, rewards for joint customer success stories and more.
“Our clients need powerful solutions and tools to deliver tangible business value, reduce overall IT costs and mitigate risks,” said Shadi Khoshab, Global Director, ITAM & Software Sourcing Services at SoftwareOne. “By enhancing and innovating its partner program, Snow is demonstrating its commitment to our strategic relationship and helping to drive our joint business forward, empowering our clients with invaluable, actionable insights that underpins successful digital transformation.”
In addition to the overall program, Snow is committed to releasing ongoing product capabilities specifically aimed at enabling its partner community. Most recently, Snow introduced two new Snow Atlas capabilities for partners to better support their customers with improved collaboration features. Customers can now give partners direct access to their Snow Atlas platform, allowing partners to manage customer environments in the cloud. In addition, partners can now create agent packages with a self-service tool in Snow Atlas without engaging Snow Support, making the end-to-end delivery more efficient.
The new Snow partner program will be available for all partners later this year. For more information about the Snow partner ecosystem or to become a Snow partner, please visit: https://www.snowsoftware.com/global-partner-program/.
About Snow Software
Snow Software is changing the way organizations understand and manage their technology consumption. Our technology intelligence platform provides comprehensive visibility and contextual insight across software, SaaS, hardware and cloud. With Snow, IT leaders can effectively optimize resources, enhance performance and enable operational agility in a hybrid world. To learn more, visit www.snowsoftware.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230201005359/en/
Contact information
Rachel Austin
Snow Software
press@snowsoftware.com
Taylor Champlin
PAN Communications
snow@pancomm.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
